David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Aurora
AUR
$12.5B
| $121M | 0.07% |
29,260,125
-5,199,718
| -15% | -$23M |
|
302
Salesforce
CRM
$171B
| $121M | 0.07% |
645,704
-133,599
| -17% | -$27.7M |
|
303
CALL
Verizon
VZ
$205B
| $120M | 0.07% |
2,397,300
-1,308,500
| -35% | -$60.6M |
|
304
Elevance Health
ELV
$86.9B
| $119M | 0.07% |
405,992
-86,004
| -17% | -$28.3M |
|
305
PUT
Reddit
RDDT
$29.5B
| $119M | 0.07% |
882,300
-59,500
| -6% | -$10.1M |
|
|
DOCU
306
DocuSign
DOCU
$11.8B
| $119M | 0.07% |
+2,501,812
| New | +$128M |
|
|
NEE.PRS
307
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.09B
| $118M | 0.07% |
2,081,000
+475,000
| +30% | +$26.2M |
|
308
PUT
Dow Inc
DOW
$23.4B
| $117M | 0.07% |
2,819,900
-758,600
| -21% | -$24.1M |
|
309
Dynatrace
DT
$14.2B
| $117M | 0.07% |
3,160,367
+1,561,358
| +98% | +$59.7M |
|
310
CVS Health
CVS
$119B
| $116M | 0.07% |
1,617,522
+542,634
| +50% | +$41.8M |
|
311
CALL
Moderna
MRNA
$57.9B
| $115M | 0.07% |
2,267,800
+401,200
| +21% | +$18.7M |
|
|
JBS
312
JBS N.V.
JBS
$45.5B
| $115M | 0.07% |
6,389,933
-815,695
| -11% | -$12.7M |
|
313
Intuitive Machines
LUNR
$2.94B
| $114M | 0.07% |
6,162,811
+2,569,287
| +71% | +$47.4M |
|
314
CALL
ASML
ASML
$677B
| $114M | 0.07% |
86,100
+6,900
| +9% | +$9.46M |
|
315
Realty Income
O
$59.2B
| $113M | 0.07% |
1,850,345
+1,678,865
| +979% | +$105M |
|
316
PUT
Seagate
STX
$193B
| $113M | 0.07% |
287,800
-22,100
| -7% | -$8.43M |
|
317
PUT
Nike
NKE
$60.5B
| $113M | 0.07% |
2,134,300
-81,000
| -4% | -$4.91M |
|
318
CALL
Toronto Dominion Bank
TD
$194B
| $112M | 0.07% |
1,200,000
-527,500
| -31% | -$50.2M |
|
319
PTC Therapeutics
PTCT
$5.83B
| $112M | 0.07% |
1,640,381
-104,610
| -6% | -$7.41M |
|
320
Vertex Pharmaceuticals
VRTX
$139B
| $111M | 0.07% |
+248,960
| New | +$116M |
|
321
Regal Rexnord
RRX
$11.1B
| $111M | 0.07% |
593,462
+231,253
| +64% | +$43M |
|
322
W.W. Grainger
GWW
$61.8B
| $111M | 0.07% |
101,750
-152,893
| -60% | -$167M |
|
|
ORCL.PRD
323
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $111M | 0.07% |
+2,421,500
| New | +$114M |
|
324
Coca-Cola
KO
$392B
| $111M | 0.07% |
1,458,989
-1,841
| -0.1% | -$139K |
|
|
Q
325
Qnity Electronics Inc
Q
$27B
| $111M | 0.07% |
960,820
-2,623,376
| -73% | -$279M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.